BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Gastrointest Endosc. Jan 16, 2026; 18(1): 114791
Published online Jan 16, 2026. doi: 10.4253/wjge.v18.i1.114791
Table 3 Oncologic outcomes, mean ± SD
Indicator
LPD group (n = 50)
OPD group (n = 50)
t/χ2
P value
MD/OR/HR (95%CI)
Lymph nodes retrieved14 ± 513 ± 40.750.45MD 1 (-0.77 to 2.77)
R0 resection (no/yes)4/466/440.340.56OR 1.57 (0.41 to 5.93)
Median OS [months (95%CI)]22 (19-25)20 (17-23)0.65HR 0.92 (0.65 to 1.31)
12-month RFS (%)78720.48HR 0.78 (0.35 to 1.74)
Adjuvant completion (no/yes)8/42 (84%)10/40 (80%)0.240.62OR 1.31 (0.47 to 3.66)


Write to the Help Desk